RE:Trump Lowers Burden On Drug Approvals Hey GV.
Wow, Trump said he was going to do certain things and he is keeping up to his promises and so far it is pretty shocking to say the least.
So if BP has Trump's "ear" and given that Trump wants quicker drug approval, given what has happened in the past week, perhaps the people accountable for the FDA will start jumping. After all, it didn't take him any time to fire Sally Yates (of course she was left over from Obama.
I'm not sure how this might impact a little biotech from Calgary without a NASDAQ listing and in fact being Canadian based might be a disadvantage.
Who knows. But I think FDA approval of phase lll BETonMACE for apabetalone would be a siignificant boast to the RVX brand although that boast will be muted by being limited to the TSX and what is worse Don M has stated he is not interested in a NASDAQ listing.
So looking forward we already have January behind us and as each week goes by we get closer to;
- the possible announcement of a new licensing deal
- resolution of financing for the next phase
- potential BETonMACE FDA approval
- the next safety approval of BoM
- the futility analysis
- possible information from the zen3694 mCRPC trial for the non-enzalutimide trial started last summer (???)
- orphan trial
- more CKD data?
GLTA
Toinv